Zobrazeno 1 - 5
of 5
pro vyhledávání: '"José Miguel Sanchez-Torres"'
Autor:
Jacobo Rogado, Nuria Romero-Laorden, José Miguel Sanchez-Torres, Ana María Ramos-Levi, Vilma Pacheco-Barcia, Ana Isabel Ballesteros, Reyes Arranz, Alicia Lorenzo, Pedro Gullon, Ana Garrido, José María Serra López-Matencio, Olga Donnay, Magdalena Adrados, Pablo Costas, Javier Aspa, Arantzazu Alfranca, Rebeca Mondejar, Ramon Colomer
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Immunotherapy is an effective treatment in advanced cancer, although predictors of response are limited. We studied whether excess weight influences the efficacy outcomes of immunotherapy. We have also evaluated the combined prognostic effect of exce
Externí odkaz:
https://doaj.org/article/c17e72bb7ac94c3c8391d210e75236de
Autor:
Pilar Garrido, Luis Paz‐Ares, Margarita Majem, Teresa Morán, José Manuel Trigo, Joaquim Bosch‐Barrera, Rosario Garcίa‐Campelo, José Luis González‐Larriba, José Miguel Sánchez‐Torres, Dolores Isla, Núria Viñolas, Carlos Camps, Amelia Insa, Óscar Juan, Bartomeu Massuti, Alfredo Paredes, Ángel Artal, Marta López‐Brea, José Palacios, Enriqueta Felip
Publikováno v:
Cancer Medicine, Vol 10, Iss 17, Pp 5878-5888 (2021)
Abstract Objectives The aim of LungBEAM was to determine the value of a novel epidermal growth factor receptor (EGFR) mutation test in blood based on BEAMing technology to predict disease progression in advanced non‐small cell lung cancer (NSCLC) p
Externí odkaz:
https://doaj.org/article/2cc59ca7f06b4dfda7263238d2a0d956
Autor:
Patricia Toquero, Carmen Blanco Fernández, María Pilar López Martí, Berta Hernández Marín, E. Beatriz Vera Cea, Ana Garrido García, Elena Méndez Carrascosa, Dulce Bañón Torres, Olga Donnay Candil, Ana Isabel Ballesteros García, José Miguel Sánchez-Torres, Pablo Costas Rojo, Rebeca Mondéjar, Ramon Colomer, Nuria Romero-Laorden
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
Background: The COVID-19 pandemic has caused mental health problems worldwide. The psychopathological implications of COVID-19 in cancer patients have rarely been addressed. Considering the increased vulnerability of oncology patients, this issue nee
Externí odkaz:
https://doaj.org/article/b8329cf138ef4bac874cbb320737c842
Autor:
Santiago Sánchez-Alonso, Giulia Setti-Jerez, Montserrat Arroyo, Tathiana Hernández, Mª Inmaculada Martos, Jose Miguel Sánchez-Torres, Ramon Colomer, Almudena R Ramiro, Arantzazu Alfranca
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Lung cancer is one of the most frequent malignancies in humans and is a major cause of death. A number of therapies aimed at reinforcing antitumor immune response, including antiprogrammed cell death protein 1 (anti-PD-1) antibodies, are s
Externí odkaz:
https://doaj.org/article/497600bd67f246cc9b6518d283ef1142
Autor:
Edurne Arriola, Ramón García Gómez, Pilar Diz, Margarita Majem, Maite Martínez Aguillo, Javier Valdivia, Alfredo Paredes, José Miguel Sánchez-Torres, Sergio Peralta Muñoz, Isidoro Barneto, Vanesa Gutierrez, Jesús Manuel Andrade Santiago, Francisco Aparisi, Dolores Isla, Santiago Ponce, David Vicente Baz, Angel Artal, Mariluz Amador, Mariano Provencio
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) over chemotherapy has been demonstrated in several clinical trials, data from clinical practice is lacking and the optima
Externí odkaz:
https://doaj.org/article/5d99fbd38d4248848d0a056c93027a23